🩺 Managing Malignant Germ Cell Tumours: Key Insights and Surveillance Strategies
🩺 Managing Malignant Germ Cell Tumours: Key Insights and Surveillance Strategies
Malignant ovarian germ cell tumours (MOGCTs) are a rare yet critical subset of ovarian cancers, constituting 1.5% of cases in Europe.
With approximately 100 diagnoses annually in the UK, effective management and meticulous follow-up are essential. Here are some crucial points and surveillance strategies for managing MOGCTs:
🔍 Early Detection and Treatment
- Prevalence: MOGCTs represent 1.5% of ovarian cancers in Europe.
- Early Diagnosis: 60-70% are diagnosed at an early stage.
- Initial Treatment: Typically treated with surgery followed by active surveillance or adjuvant chemotherapy.
- Chemotherapy Sensitivity: MOGCTs are more responsive to chemotherapy compared to other ovarian tumour
🏥 Surgical Considerations
- Radical Surgery: Recommended for women who have completed their family or are beyond childbearing age, including total hysterectomy and bilateral salpingo-oophorectomy.
- Less Invasive Staging: Current trends emphasize less invasive surgical staging to reduce morbidity associated with full lymphadenectomy.
💊 Chemotherapy Regimens and Complications
- Standard Regimens:
- if age is above...EP (Etoposide and Cisplatin)
- if age is below 40years.BEP (Bleomycin, Etoposide, and Cisplatin)
- Adverse Effects: Potential short and long-term complications include:
- Ototoxicity and hearing loss
- Nephrotoxicity
- Pulmonary dysfunction
- Raynaud's phenomenon
- Avascular necrosis
- Secondary malignancies (e.g., acute myeloid leukemia)
Also premature ovarian insufficiency in 3%
- Fertility Preservation:Oocyte cryopreservation is advised before chemotherapy due to the risk of inferility.
📅 Active Surveillance
- Recurrence Risk: Highest in the first two years post-treatment.
- Surveillance Plan:
Based on RCOG and European guidelines, involving:
- Regular examinations
- Pelvic ultrasounds
- Tumour marker assessments
- Chest X-rays (CXR)
- CT abdomen and pelvis (CTAP)
- The program described by Vasquez and Rustin includes a demanding visiting schedule to detect recurrence over a 10-year period.
---
Comments
Post a Comment